UBS Keeps Their Buy Rating on Gossamer Bio (GOSS)
December 07 2022 - 11:25AM
TipRanks
In a report released today, Eliana Merle from UBS maintained a Buy
rating on Gossamer Bio (GOSS - Research Report), with a price
target of $8.00. The company's shares opened today at
$1.79.According to TipRanks, Merle is an analyst with an average
return of -4.6% and a 38.64% success rate. Merle covers the
Healthcare sector, focusing on stocks such as IVERIC bio, uniQure,
and Moderna.The word on The Street in general, suggests a Moderate
Buy analyst consensus rating for Gossamer Bio with a $9.44 average
price target, which is a 427.37% upside from current levels.
https://www.tipranks.com/news/blurbs/ubs-keeps-their-buy-rating-on-gossamer-bio-goss?utm_source=advfn.com&utm_medium=referral
Gossamer Bio (NASDAQ:GOSS)
Historical Stock Chart
From Nov 2023 to Dec 2023
Gossamer Bio (NASDAQ:GOSS)
Historical Stock Chart
From Dec 2022 to Dec 2023